APA (7th ed.) Citation

D, S., A, R., M, A., D, M., PEP, C., OS, S., . . . ES, B. (2025). Can iodixAnol ReducE the incidence of adverse renal or cardiac events in chronic total occlusion interventions (CARE-CTO): A substudy of the PROGRESS-CTO registry. The Journal of invasive cardiology, 37(9), . https://doi.org/10.25270/jic/25.00004

Chicago Style (17th ed.) Citation

D, Strepkos, et al. "Can IodixAnol ReducE the Incidence of Adverse Renal or Cardiac Events in Chronic Total Occlusion Interventions (CARE-CTO): A Substudy of the PROGRESS-CTO Registry." The Journal of Invasive Cardiology 37, no. 9 (2025). https://doi.org/10.25270/jic/25.00004.

MLA (9th ed.) Citation

D, Strepkos, et al. "Can IodixAnol ReducE the Incidence of Adverse Renal or Cardiac Events in Chronic Total Occlusion Interventions (CARE-CTO): A Substudy of the PROGRESS-CTO Registry." The Journal of Invasive Cardiology, vol. 37, no. 9, 2025, https://doi.org/10.25270/jic/25.00004.